1. Home
  2. TALKW vs NAMSW Comparison

TALKW vs NAMSW Comparison

Compare TALKW & NAMSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TALKW
  • NAMSW
  • Stock Information
  • Founded
  • TALKW N/A
  • NAMSW N/A
  • Country
  • TALKW United States
  • NAMSW Netherlands
  • Employees
  • TALKW 472
  • NAMSW 29
  • Industry
  • TALKW Medical/Nursing Services
  • NAMSW Biotechnology: Pharmaceutical Preparations
  • Sector
  • TALKW Health Care
  • NAMSW Health Care
  • Exchange
  • TALKW Nasdaq
  • NAMSW Nasdaq
  • Market Cap
  • TALKW N/A
  • NAMSW N/A
  • IPO Year
  • TALKW 2020
  • NAMSW N/A
  • Fundamental
  • Price
  • TALKW $0.10
  • NAMSW $9.45
  • Analyst Decision
  • TALKW
  • NAMSW
  • Analyst Count
  • TALKW 0
  • NAMSW 0
  • Target Price
  • TALKW N/A
  • NAMSW N/A
  • AVG Volume (30 Days)
  • TALKW N/A
  • NAMSW N/A
  • Earning Date
  • TALKW N/A
  • NAMSW N/A
  • Dividend Yield
  • TALKW N/A
  • NAMSW N/A
  • EPS Growth
  • TALKW N/A
  • NAMSW N/A
  • EPS
  • TALKW N/A
  • NAMSW N/A
  • Revenue
  • TALKW N/A
  • NAMSW N/A
  • Revenue This Year
  • TALKW N/A
  • NAMSW N/A
  • Revenue Next Year
  • TALKW N/A
  • NAMSW N/A
  • P/E Ratio
  • TALKW N/A
  • NAMSW N/A
  • Revenue Growth
  • TALKW N/A
  • NAMSW N/A
  • 52 Week Low
  • TALKW N/A
  • NAMSW N/A
  • 52 Week High
  • TALKW N/A
  • NAMSW N/A
  • Technical
  • Relative Strength Index (RSI)
  • TALKW N/A
  • NAMSW 50.58
  • Support Level
  • TALKW N/A
  • NAMSW $9.40
  • Resistance Level
  • TALKW N/A
  • NAMSW $10.14
  • Average True Range (ATR)
  • TALKW 0.00
  • NAMSW 0.48
  • MACD
  • TALKW 0.00
  • NAMSW 0.06
  • Stochastic Oscillator
  • TALKW 0.00
  • NAMSW 29.67

About TALKW Talkspace Inc. Warrant

Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue primarily stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.

About NAMSW NewAmsterdam Pharma Company N.V. Warrant

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

Share on Social Networks: